Cancer Family
Head and Neck Melanocytic Neoplasm
CI-CAN-00000193Explore in graph →
Non-malignant3 active trials
- NCIt
- C173488
Loading cancer entity…
Cancer Family
CI-CAN-00000193Explore in graph →
Clinical trials
9 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02748564 | Aldesleukin and Pembrolizumab in Treating Patients With Stage III-IV Melanoma | terminated | Phase 2 | 10 | Rutgers, The State University of New JerseyOTHER | 1 | Aug 3, 2023 | clinicaltrials |
Data updated 22 days agoSource updated Aug 3, 2023source: clinicaltrials